Legacy Windows systems still power more than half of Europe’s pharmaceutical manufacturing floors. At the same time, ransomware, data breaches and a host of cyber-related disruptions are hitting pharma harder than ever. The question on many a mind: just how exposed are we—and how should we keep pace?
To give you a ‘window’ (ahem) into the answer, we surveyed over 530 OT and ICS cybersecurity decision-makers across eight European industries, including pharma, to find out:
